OUR EXPERTS
Toxicology
Meet some of the renowned scientists, physicians, and engineers who help BlueRidge clients achieve their most important life science goals.

Swipe to learn more about our experts
-
Susan Borghoff, MSPH, PhD, DABT
PRINCIPAL SCIENTIST, VICE PRESIDENT, THE CENTER OF EXCELLENCE FOR 21ST CENTURY TOXICOLOGY
ToxStrategiesMy expertise includes developing strategies for safety testing of agents using traditional and 21st century tools and technologies to meet regulatory requirements and identify alternative chemistries for context of use. I have 35+ years of experience as a toxicologist in studying mechanisms of adverse disease outcomes and the relevance of these responses for assessing human risk.
-
Candace L. Doepker, PhD
SENIOR VICE PRESIDENT, FOODS AND CONSUMER PRODUCTS
ToxStrategiesMy specialty is in food and consumer product safety. I worked for 16 years in industry in global product stewardship supporting the safety of various billion dollar brands. I have consulted at ToxStrategies for 14 years and I oversee a group of innovative thinkers who can help assess safety and regulatory risk throughout the entire supply chain. I am passionate about ensuring our deliverables are scientifically sound, delivered in a timely manner and easy to understand.
-
Brent L. Finley, PhD, DABT
SENIOR VICE PRESIDENT, CAUSATION ANALYSIS
ToxStrategiesMy specialty is to quantify the potential health risks associated with exposure to chemicals in consumer products and pharmaceuticals, the home, the workplace, and the environment. I have a background in toxicology and pharmacology and have been involved in quantitative health risk assessment for 30 years as a consultant and expert witness.
-
Chad Thompson, PhD, MBA
SENIOR MANAGING SCIENTIST
ToxStrategiesMy specialty is environmental and human health risk assessment, including mechanistic and dose-response analyses. As a former AAAS Fellow and EPA staff scientist with over 15 years of industry consulting experience, I have a unique perspective and understanding of human health risk assessment and policy. As part of my work, I help design research programs, place studies, interpret results, and communicate findings to stakeholders that directly address critical risk assessment questions. My passion is to utilize the best available science and assessment methodologies to develop scientifically sound risk assessments.
-
Kristina Ulrich, PhD, ERT
SENIOR MANAGING SCIENTIST, DIRECTOR, NONCLINICAL TOXICOLOGY
ToxStrategiesI specialize in the design and implementation of nonclinical safety strategies to facilitate the advancement of novel therapeutics into clinical development and beyond. I have 20+ years of experience as a toxicologist/drug developer from a number of large pharmaceutical companies, as well being a former non-clinical assessor at MHRA. I leverage this expertise to enable my clients to make informed decisions about their safety challenges and to support streamlined progression of their programs.
-
Daniele Wikoff, PhD
CHIEF SCIENTIFIC OFFICER
ToxStrategiesAs the Chief Scientific Officer, I specialize in the use of evidence-based methods in support of hazard and safety assessments for food ingredients and contaminants, industrial chemicals, cosmetic ingredients, over-the-counter pharmaceuticals, and consumer products.
-
Marcie Wood, PhD
PRINCIPAL SCIENTIST, SENIOR VICE PRESIDENT, NONCLINICAL TOXICOLOGY
ToxStrategiesMy expertise includes developing nonclinical toxicology program technical and regulatory strategies to support advancement of therapeutic products into clinical trials and beyond. I have 20+ years of experience as a toxicologist, drug development professional, and former FDA leader, and I leverage this background to support clients with nonclinical challenges at all stages of drug development.